How transcription and RNA processing drive Ewing sarcoma
Dysregulated transcription processes in Ewing sarcoma
Researchers are looking at how a fusion gene causes abnormal RNA transcription and splicing in Ewing sarcoma in children and young adults.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Research Inst Nationwide Children's Hosp NIH-funded |
| Lab location | 1 site (Columbus, United States) |
| Project ID | NIH-11330324 on NIH RePORTER |
What this research studies
From my perspective as a patient or family member, the team studies how the EWSR1-FLI1 fusion makes RNA polymerase II overly active and leads to toxic RNA structures called R-loops that disrupt normal RNA splicing. They use lab work on tumor cells and genomic RNAi screens to find which RNA processing steps EwS cells are most dependent on. The researchers also study proteins like CDK7, CDK9, and DHX9 that interact with the fusion to find molecular weak points. The goal is to reveal targets that could be used for new treatments or to guide future clinical trials.
Who could benefit from this research
Good fit: Children and young adults diagnosed with Ewing sarcoma could potentially contribute tumor samples or be candidates for future trials based on this research.
Not a fit: People without Ewing sarcoma or those needing immediate clinical therapy should not expect direct, short-term benefits from this laboratory-focused research.
Why it matters
Potential benefit: If successful, this work could point to new targeted treatments or biomarkers that improve outcomes and reduce side effects for people with Ewing sarcoma.
How similar studies have performed: Prior laboratory studies, including the team's earlier Nature report linking the fusion to hyperactive transcription and targets like CDK7/CDK9, support the approach, but translating these findings into effective patient treatments remains early-stage.
Where this research is happening
Columbus, United States
- Research Inst Nationwide Children's Hosp — Columbus, United States (Active)
Researchers
- Principal investigator: Bishop, Alexander James — Research Inst Nationwide Children's Hosp
- Study coordinator: Bishop, Alexander James
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.